U.S. flag

An official website of the United States government

NM_022089.4(ATP13A2):c.2836A>T (p.Ile946Phe) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (4 submissions)
Last evaluated:
Jan 1, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000116438.28

Allele description [Variation Report for NM_022089.4(ATP13A2):c.2836A>T (p.Ile946Phe)]

NM_022089.4(ATP13A2):c.2836A>T (p.Ile946Phe)

Gene:
ATP13A2:ATPase cation transporting 13A2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.13
Genomic location:
Preferred name:
NM_022089.4(ATP13A2):c.2836A>T (p.Ile946Phe)
HGVS:
  • NC_000001.11:g.16988161T>A
  • NG_009054.1:g.28768A>T
  • NM_001141973.3:c.2821A>T
  • NM_001141974.3:c.2704A>T
  • NM_022089.4:c.2836A>TMANE SELECT
  • NP_001135445.1:p.Ile941Phe
  • NP_001135446.1:p.Ile902Phe
  • NP_071372.1:p.Ile946Phe
  • LRG_834t1:c.2836A>T
  • LRG_834:g.28768A>T
  • LRG_834p1:p.Ile946Phe
  • NC_000001.10:g.17314656T>A
  • NM_022089.2:c.2836A>T
  • NM_022089.3:c.2836A>T
  • Q9NQ11:p.Ile946Phe
Protein change:
I902F
Links:
UniProtKB: Q9NQ11#VAR_058461; dbSNP: rs55708915
NCBI 1000 Genomes Browser:
rs55708915
Molecular consequence:
  • NM_001141973.3:c.2821A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001141974.3:c.2704A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_022089.4:c.2836A>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
3

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000150363Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2007)
Uncertain significance
(Feb 7, 2014)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001715510Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jan 9, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV001759516GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely benign
(Jan 8, 2021)
germlineclinical testing

Citation Link,

SCV004701251CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Uncertain significance
(Jan 1, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
germlineunknown2not providednot providednot providednot providedclinical testing
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.

Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE; Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee..

Genet Med. 2008 Apr;10(4):294-300. doi: 10.1097/GIM.0b013e31816b5cae.

PubMed [citation]
PMID:
18414213

ATP13A2 variability in Parkinson disease.

Vilariño-Güell C, Soto AI, Lincoln SJ, Ben Yahmed S, Kefi M, Heckman MG, Hulihan MM, Chai H, Diehl NN, Amouri R, Rajput A, Mash DC, Dickson DW, Middleton LT, Gibson RA, Hentati F, Farrer MJ.

Hum Mutat. 2009 Mar;30(3):406-10. doi: 10.1002/humu.20877.

PubMed [citation]
PMID:
19085912
PMCID:
PMC2650009
See all PubMed Citations (5)

Details of each submission

From Genetic Services Laboratory, University of Chicago, SCV000150363.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV001715510.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (4)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided2not providednot providednot provided

From GeneDx, SCV001759516.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Reported in the heterozygous state in an individual with Parkinson disease; however, a second ATP13A2 variant was not detected and I946F was observed in an unaffected control (Djarmati et al., 2009); This variant is associated with the following publications: (PMID: 19458722, 18075584, 12169656, 19705361, 19085912, 18075585)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV004701251.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Oct 8, 2024